Editorial: Metabolic Reprogramming and Cancer Progression

Overview

Journal Transl Oncol

Specialty Oncology

Date 2023 Jan 12

PMID 36635022

Authors

Qinan Yin

Nabin Poudel

Ziyi Liu

Affiliations

Soon will be listed here.

References

Fu D, Hu Z, Xu X, Dai X, Liu Z . Key signal transduction pathways and crosstalk in cancer: Biological and therapeutic opportunities. Transl Oncol. 2022; 26:101510. PMC: 9486121. DOI: 10.1016/j.tranon.2022.101510. View

Qiao Y, Yu X, Zhou B, Zhang K, Huang J, Liao J . KIAA1529 regulates RAD51 expression to confer PARP inhibitors resistance in ovarian cancer. Transl Oncol. 2022; 24:101497. PMC: 9352548. DOI: 10.1016/j.tranon.2022.101497. View

Huang J, Zhou M, Zhang H, Fang Y, Chen G, Wen J . Characterization of the mechanism of Scutellaria baicalensis on reversing radio-resistance in colorectal cancer. Transl Oncol. 2022; 24:101488. PMC: 9307497. DOI: 10.1016/j.tranon.2022.101488. View

Yan X, Yan W, Fu X, Xu Y, Zhu N, Qiu C . Single nucleotide mutation changes the capability of CCN3 in osteosarcoma cell invasion and differentiation. Transl Oncol. 2022; 24:101485. PMC: 9294644. DOI: 10.1016/j.tranon.2022.101485. View

Yang X, Liu Y, Zhou X, Chen K, Xu J, Xu S . Circular RNA 0010117 promotes aggressive glioblastoma behavior by regulating the miRNA-6779-5p/SPEN axis. Transl Oncol. 2022; 25:101515. PMC: 9468456. DOI: 10.1016/j.tranon.2022.101515. View

Zheng X, Ma H, Wang J, Huang M, Fu D, Qin L . Energy metabolism pathways in breast cancer progression: The reprogramming, crosstalk, and potential therapeutic targets. Transl Oncol. 2022; 26:101534. PMC: 9482139. DOI: 10.1016/j.tranon.2022.101534. View

Du Y, Yang Y, Zhang W, Yang C, Xu P . Human β-defensin-3 and nuclear factor-kappa B p65 synergistically promote the cell proliferation and invasion of oral squamous cell carcinoma. Transl Oncol. 2022; 27:101582. PMC: 9676516. DOI: 10.1016/j.tranon.2022.101582. View

Zeng L, Luo X, Zhang Z, Wang Z, Qian J . Long non-coding FAM201A accelerates the tumorigenesis and progression of colorectal cancer through miR-3163/MACC1 axis. Transl Oncol. 2022; 25:101490. PMC: 9468577. DOI: 10.1016/j.tranon.2022.101490. View

Xiong W, Liu D, Chen X, Liu L, Xiao W . lncRNA JPX modulates malignant progress of osteosarcoma through targeting miR-33a-5p and PNMA1 regulatory loop. Transl Oncol. 2022; 25:101504. PMC: 9502696. DOI: 10.1016/j.tranon.2022.101504. View

10.

Yang X, Shen Z, Tian M, Lin Y, Li L, Chai T . LncRNA C9orf139 can regulate the progression of esophageal squamous carcinoma by mediating the miR-661/HDAC11 axis. Transl Oncol. 2022; 24:101487. PMC: 9352544. DOI: 10.1016/j.tranon.2022.101487. View

11.

Xiao X, Chen H, Yang L, Xie G, Shimuzu R, Murai A . Concise review: Cancer cell reprogramming and therapeutic implications. Transl Oncol. 2022; 24:101503. PMC: 9364012. DOI: 10.1016/j.tranon.2022.101503. View